2023 annual financial data
Aldeyra Therapeutics 2023 Operating margin
Aldeyra Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -42,794,083 USD and net income was -37,542,510 USD.
Operating cash flow was -30,326,128 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -42,794,083 USD
- Net income
- -37,542,510 USD
- Operating cash flow
- -30,326,128 USD